+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Tears - Global Market Trajectory & Analytics

  • ID: 2228007
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Akorn, Inc.
  • Allergan, Inc.
  • Bausch & Lomb Inc.
  • Johnson & Johnson
  • Novartis International AG
Global Artificial Tears Market to Reach $1.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Artificial Tears estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$1.9 Billion by 2027, growing at a CAGR of 2.4% over the period 2020-2027.





The U.S. Market is Estimated at $436.6 Million, While China is Forecast to Grow at 4.5% CAGR

The Artificial Tears market in the U.S. is estimated at US$436.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$378.2 Million by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.5% and 1.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.1% CAGR.

Select Competitors (Total 49 Featured):
  • Abbott Medical Optics Inc.
  • Akorn, Inc.
  • Allergan, Inc.
  • Bausch & Lomb Inc.
  • Johnson & Johnson
  • Novartis International AG
Frequently Asked Questions about the Global Market for Artificial Tears

What is the estimated value of the Global Market for Artificial Tears?

The Global Market for Artificial Tears was estimated to be valued at $1.6 Billion in 2020.

What is the growth rate of the Global Market for Artificial Tears?

The growth rate of the Global Market for Artificial Tears is 2.5%, with an estimated value of $1.9 Billion by 2027.

What is the forecasted size of the Global Market for Artificial Tears?

The Global Market for Artificial Tears is estimated to be worth $1.9 Billion by 2027.

Who are the key companies in the Global Market for Artificial Tears?

Key companies in the Global Market for Artificial Tears include Abbott Medical Optics Inc., Akorn, Inc., Allergan, Inc., Bausch & Lomb Inc. and Novartis International AG.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Akorn, Inc.
  • Allergan, Inc.
  • Bausch & Lomb Inc.
  • Johnson & Johnson
  • Novartis International AG

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Dry Eyes - A Lucrative Segment of Ophthalmology Market
  • Recent Market Activity
  • Artificial Tears: The First Line and Mainstay Treatment for Dry Eyes
  • Other Therapies for Dry Eye
  • Current & Future Analysis
  • Developing Countries Display Strong Growth Prospects
  • Under-reporting of DES Condition Stifles Market Opportunities
  • Prevalence and Incidence of Dry Eye Syndrome
  • Select Stats on Prevalence Rates
  • Concentrated Prescription Dry Eye Products Market Benefits OTC Market

2. FOCUS ON SELECT PLAYERS
  • Allergan plc (Ireland)
  • Akorn, Inc. (USA)
  • Bausch & Lomb Incorporated (USA)
  • Johnson & Johnson (USA)
  • Novartis International AG (Switzerland)
  • Alcon, Inc. (Switzerland)
  • Santen Pharmaceuticals Co, Ltd. (Japan)

3. MARKET TRENDS & DRIVERS
  • Companies Focus on New Formulations to Improve Results
  • Preference for Preservative-Free Artificial Tears on Rise
  • Management of Dry Eyes Post Eye Surgery Drives Demand for Artificial Tears
  • Rise in Mobile Workforce and Number of Smartphone Addicts Spurs Growth Prospects
  • An Upswing in Contact Lens Wearers Unfolds New Opportunities
  • Manufacturers Focus Efforts on Formulating the Right Artificial Tears for Contact Lens Wearers
  • Environmental Factors Play an Important Role
  • Nanotechnology and Other Innovative Delivery Techniques Gain Attention in DES Treatment
  • Direct-to-Customer Promotions: A Primary Marketing Strategy
  • Aging Population - A Major Growth Driver
  • Multi-Factorial Nature of Dry Eye Poses Challenges to Drug Makers
  • Market Challenges
  • Lack of Clear Product Differentiation
  • Drug Formulation Fraught with Difficulties
  • Low Patient Compliance Limits Market Opportunities

4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Current & Future Analysis for Artificial Tears by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 2: World Historic Review for Artificial Tears by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 3: World 15-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
  • III. MARKET ANALYSIS
  • UNITED STATES
  • TABLE 4: USA Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 5: USA Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • CANADA
  • TABLE 6: Canada Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 7: Canada Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • JAPAN
  • TABLE 8: Japan Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 9: Japan Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • CHINA
  • TABLE 10: China Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 11: China Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • EUROPE
  • TABLE 12: Europe Current & Future Analysis for Artificial Tears by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 13: Europe Historic Review for Artificial Tears by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 14: Europe 15-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
  • FRANCE
  • TABLE 15: France Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 16: France Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • GERMANY
  • TABLE 17: Germany Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 18: Germany Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • ITALY
  • TABLE 19: Italy Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 20: Italy Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • UNITED KINGDOM
  • TABLE 21: UK Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 22: UK Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • SPAIN
  • TABLE 23: Spain Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 24: Spain Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • RUSSIA
  • TABLE 25: Russia Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 26: Russia Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • REST OF EUROPE
  • TABLE 27: Rest of Europe Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 28: Rest of Europe Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • ASIA-PACIFIC
  • TABLE 29: Asia-Pacific Current & Future Analysis for Artificial Tears by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 30: Asia-Pacific Historic Review for Artificial Tears by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 31: Asia-Pacific 15-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
  • AUSTRALIA
  • TABLE 32: Australia Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 33: Australia Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • INDIA
  • TABLE 34: India Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 35: India Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • SOUTH KOREA
  • TABLE 36: South Korea Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 37: South Korea Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • REST OF ASIA-PACIFIC
  • TABLE 38: Rest of Asia-Pacific Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 39: Rest of Asia-Pacific Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • LATIN AMERICA
  • TABLE 40: Latin America Current & Future Analysis for Artificial Tears by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 41: Latin America Historic Review for Artificial Tears by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 42: Latin America 15-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
  • ARGENTINA
  • TABLE 43: Argentina Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 44: Argentina Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • BRAZIL
  • TABLE 45: Brazil Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 46: Brazil Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • MEXICO
  • TABLE 47: Mexico Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 48: Mexico Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • REST OF LATIN AMERICA
  • TABLE 49: Rest of Latin America Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 50: Rest of Latin America Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • MIDDLE EAST
  • TABLE 51: Middle East Current & Future Analysis for Artificial Tears by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 52: Middle East Historic Review for Artificial Tears by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 53: Middle East 15-Year Perspective for Artificial Tears by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
  • IRAN
  • TABLE 54: Iran Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 55: Iran Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • ISRAEL
  • TABLE 56: Israel Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 57: Israel Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • SAUDI ARABIA
  • TABLE 58: Saudi Arabia Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 59: Saudi Arabia Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • UNITED ARAB EMIRATES
  • TABLE 60: UAE Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 61: UAE Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • REST OF MIDDLE EAST
  • TABLE 62: Rest of Middle East Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 63: Rest of Middle East Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • AFRICA
  • TABLE 64: Africa Current & Future Analysis for Artificial Tears by Segment - Artificial Tears - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 65: Africa Historic Review for Artificial Tears by Segment - Artificial Tears Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

IV. COMPETITION
  • Total Companies Profiled: 49
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Medical Optics Inc.
  • Akorn, Inc.
  • Allergan, Inc.
  • Bausch & Lomb Inc.
  • Johnson & Johnson
  • Novartis International AG
Note: Product cover images may vary from those shown